Author(s): Martin PD, Argyle DJ
Abstract Share this page
Abstract Skin cancer is one of the most commonly diagnosed cancers in the world today in both humans and our pet population. Advances in molecular techniques are now affording us an opportunity to develop therapeutics targeted at specific cancer-related cellular pathways. However, despite progress in conventional treatments, such as chemotherapy and radiation, and the new targeted therapies, some cancers, such as melanoma and cutaneous lymphoma, continue to cause significant mortality and morbidity. This short synopsis is not complete but is aimed at providing an insight into current advanced treatments and horizon therapies for cutaneous malignancies in dogs and cats with comparative aspects. © 2013 The Authors. Veterinary Dermatology © 2013 ESVD and ACVD.
This article was published in Vet Dermatol
and referenced in Journal of Clinical & Experimental Pathology